Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermedia

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-09-0661
Issue:2010: 103/5 (May) pp. 875–1108
Pages:989-993

Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermedia

M. Karimi (1), H. Bagheri (2), F. Rastgu (1), E. A. Rachmilewitz (3)

(1) Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran; (2) Radiology Department, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran; (3) Department of Hematology, The Edith Wolfson Medical Center, Holon, Israel

Summary

One complication in patients with β-thalassaemia who had prolonged survival is chronic hypercoagulable state, which results in thromboembolic events involving major organs including the brain. We determined the prevalence of microthrombosis in the brain in an asymptomatic subgroup of patients with b-thalassaemia intermedia (TI) who had undergone splenectomy. This retrospective review included 200 patients with TI diagnosed on the basis of blood count, haemoglobin (Hb) electrophoresis and clinical data. Their ages ranged from 18 to 34 years, 19 (63.3%) were women and 11 (36.7%) were men. We selected 30 patients at random who fulfilled the inclusion criteria: Hb concentration >7 g/dl), splenectomy and platelet count >500,000/ml. Their mean Hb concentration was 8.4 g/dl and their mean ferritin concentration was 519 ng/ml. Magnetic resonance imaging (MRI) was done in every patient, and the findings were interpreted by an expert neuroradiologist. Imaging studies showed pathological findings in 28% of the patients. Six had changes in the white matter suggestive of ischaemia and two had evidence of small infarctions. Conclusion: 1) In this small subset of patients diagnostic magnetic resonance imaging to monitor early asymptomatic or subclinical vascular damage in the brain can be considered when they reach the age of 20 years, and repeated every 3–5 years. 2) Treatment with antiplatelet aggregants is suggested in patients with documented asymptomatic brain ischaemia. 3) These results require confirmation in a larger group of similar patients with other types of thalassaemia who are multitransfused or have an intact spleen.

Keywords

Magnetic Resonance Imaging, brain ischaemia, β-thalassaemia intermedia

DOI

http://dx.doi.org/10.1160/TH09-09-0661

You may also be interested in...

1.

R. Poma1, H. Chambers2, R. C. da Costa3, N. B. Konyer4, S. Nykamp1, H. Dobson1, N. W. Milgram5

VCOT - Veterinary and Comparative Orthopaedics and Traumatology 2008 21 3: 238-242

2.

Free PDF of English version

I. Foltin1, 2, A. Brühschwein1, K. Rieden2, U. Matis1

Tierärztliche Praxis Kleintiere 2008 36 2: 75-88

3.

A. Brünott1, E. Auriemma2, A. B. M. Rijkenhuizen1

Tierärztliche Praxis Großtiere 2007 35: 63-68



Articles

You've 149 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...